I am confused about the inner distance setting. From the manual file, it should be set to (fragementlength-2*readslength , eg: 300-2*50=100). But if the distance counting is based on genome location, then the distance between the pairs should be (fragementlength-2*readslength+inserted_introns_length). Does anybody know how tophat manage the intron insertion?
Unconfigured Ad
Collapse
X
-
I think that the mate inner distances is set in order to detect whether the mates are in different exons etc. That is, if the distance is much larger/smaller than the 200 (300-2*50) that the software has been told to expect, something interesting might be going on.
-
-
Hi snp_analyser. I'm afraid there is no good value - the inner distances depend on the sizes of your fragments and the lengths of your reads, which are experiment specific.
We typically use a tool like Bowtie to help us find our fragment sizes empirically. We run a paired-end alignment with Bowtie, using default parameters for -I and -X. We then examine the output to see, in general, how far apart the reads in a pair as aligned. This indicates the mate inner distance.
In terms of terminology, the "gap" or "inner distance" is the distance between the aligned reads (not counting the reads themselves). The "insert size", on the other hand, includes the reads themselves, so can be thought of as the "fragment size".
If you look at Bowtie output, the alignment position of a read is the position of the first base in the read (from the perspective of the forward reference strand). This means that if you subtract the alignment positions of the two reads in a pair, the result is actually "inner distance" + "read length". So you will need to subtract the read length to get the inner distance.
You should probably write (or find) a script to do this for you to ensure you examine enough pairs to get a representative feel for the value. Our data typically shows a normally distributed inner distance.
Comment
-
Latest Articles
Collapse
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
-
by SEQadmin2
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...-
Channel: Articles
07-08-2026, 05:17 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 07-24-2026, 12:17 PM
|
0 responses
29 views
0 reactions
|
Last Post
by SEQadmin2
07-24-2026, 12:17 PM
|
||
|
Started by SEQadmin2, 07-23-2026, 11:41 AM
|
0 responses
21 views
0 reactions
|
Last Post
by SEQadmin2
07-23-2026, 11:41 AM
|
||
|
Started by SEQadmin2, 07-20-2026, 11:10 AM
|
0 responses
212 views
0 reactions
|
Last Post
by SEQadmin2
07-20-2026, 11:10 AM
|
||
|
Started by SEQadmin2, 07-13-2026, 10:26 AM
|
0 responses
78 views
0 reactions
|
Last Post
by SEQadmin2
07-13-2026, 10:26 AM
|
Comment